| 1 |
34503223 | Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters. | 2021 Sep 1 |
1 |
| 2 |
32513400 | Drug eruptions associated with tumor therapy: Great imitators. | 2020 Mar - Apr |
1 |
| 3 |
24711706 | Potential of antibody-drug conjugates and novel therapeutics in breast cancer management. | 2014 |
1 |
| 4 |
21947696 | Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin. | 2012 Mar |
2 |
| 5 |
22521649 | EGFR mutations as a predictive marker of cytotoxic chemotherapy. | 2012 Aug |
2 |
| 6 |
21636554 | Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy. | 2011 Jun 1 |
2 |
| 7 |
20064265 | Chemosensitization of cancer cells by siRNA using targeted nanogel delivery. | 2010 Jan 11 |
2 |
| 8 |
20085868 | Subsequent chemotherapy improves survival outcome in advanced non-small-cell lung cancer with acquired tyrosine kinase inhibitor resistance. | 2010 Jan |
2 |
| 9 |
20534991 | Immunohistochemical study of HER2 and TUBB3 proteins in extramammary Paget disease. | 2010 Aug |
1 |
| 10 |
21048911 | Limitations in Adjuvant Breast Cancer Therapy: The Predictive Potential of Pharmacogenetics and Pharmacogenomics. | 2008 |
1 |
| 11 |
17036319 | Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231). | 2007 Jan 1 |
2 |
| 12 |
17505004 | Enhancement of docetaxel-induced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in squamous cell carcinoma of the head and neck. | 2007 May 15 |
1 |
| 13 |
11981003 | Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer. | 2002 May 1 |
3 |
| 14 |
12435109 | Overcoming multidrug resistance in taxane chemotherapy. | 2002 Sep |
2 |